PhP and NHS Wales partner to provide unlimited access to MedicinesComplete

New three-year goals launched to advance pharmacy services in Wales

25 September 2025

This news story was published when the organisation was the Royal Pharmaceutical Society. New goals to transform pharmacy services across Wales over the next three years have been launched today, setting out the next steps in 'Pharmacy: Delivering a Healthier Wales', the long-term 2030 vision for maximising the expertise of pharmacy teams to improve patient care. Since the vision was first published in 2019, pharmacy teams have made remarkable progress despite the challenges of the COVID-19 pandemic. With investment and workforce development, patients now benefit from more clinical services closer to home, while the rollout of electronic prescribing is underway across all settings. The 2025–2028 goals build on this progress and were shaped through engagement with more than 500 pharmacists, pharmacy technicians, support staff, students, patient representatives and healthcare partners. They focus on spreading and scaling services to ensure equitable access to care, wherever people live and however they access them. Priorities include embedding prevention and wellbeing, delivering electronic prescribing across Wales, and transforming aseptic services, starting with a new radiopharmacy facility in South East Wales. Other aims include increasing patient access to pharmacist independent prescribers, expanding the skill mix of pharmacy teams, and creating innovative career pathways that support multi-disciplinary care. Elen Jones, RPS Director for Wales, said: "This is an exciting moment for pharmacy as we begin another three-year commitment to transformation. The 2025–2028 goals take us closer to our 2030 vision, while recognising the pressures the workforce continues to face. Thanks to the passion and dedication of pharmacy teams across Wales, I am confident we are on track. "Progress has only been possible through the collective efforts of pharmacy teams and our partners. The PDaHW programme delivery board, supported by four themed subgroups, has driven momentum and kept goals in sharp focus. Their diverse membership has ensured our work reflects the needs of patients and the whole pharmacy workforce. "When barriers arise, these are escalated to the Welsh Pharmaceutical Committee, whose oversight ensures challenges are addressed and the voice of pharmacy is heard. I would also like to thank the RPS team for leading the development of this update, which captures the energy and commitment of colleagues right across Wales.” Read the new goals in Welsh. Read the new goals in English.

Our response to Guild of Healthcare Pharmacists open letter

25 October 2024

This letter was published when the organisation was the Royal Pharmaceutical Society. Following the open letter sent to us by the Guild of Healthcare Pharmacists (GHP), we have responded to them and have set out our response below: Dear Rob, Thank you for your recent letter concerning our Constitution and Governance Review. The Royal Pharmaceutical Society (RPS) is currently engaged in a conversation with our members and the wider profession about our proposals for change and our ambition to become a Royal College. These proposals are being set out for pharmacists and pharmaceutical scientists (whether members or not) via a series of ‘roadshow’ engagement events across GB during October and November. A recurring focus of the conversations we are having at these events is our ambitions to integrate credentialing into the profession; some of the questions about credentialing are echoed in the Guild Council’s letter. We are happy to clarify the benefits we envisage will flow from the further embedding of credentialing and to address some of the other points raised by the Guild Council. The key purpose of RPS credentialing is to protect the public and the integrity of the pharmacy profession through assuring patient-focused pharmacists (i.e., roles that have a direct impact on individual patients and/or patient populations) working at advancing levels of post-registration practice. Defining and assuring post-registration professional standards is a fundamental activity for a royal college and thus fully aligned with our proposals for change. Credentialing provides considerable benefits for pharmacists and the system. For a pharmacist, credentialing can support a standard professional career structure which offers potential for advancement. Credentialing also engenders professional confidence and pride, increases professional cohesion and provides a mechanism by which the skills and capabilities of an individual are recognised. We have also heard from candidates about the benefits they have gained from successfully undertaking credentialing; including increased confidence, improved practice and greater integration within the wider multidisciplinary team. For the employer and wider system, credentialing provides an objective and validated assurance mechanism for employee capability within and across organisations which can inform fair and valid career progression and recruitment decisions, assure consistency across the system and improve workforce portability. It also provides a mechanism by which other health professionals and patients can recognise the level of practice of the pharmacy workforce. We have heard of pharmacists having to ‘re-prove’ their level of practice when they have moved employer, sector, or location, with some having to restart a training pathway from scratch to meet specific regional or national training requirements. This is not efficient or effective for the service, the employer or the pharmacist and is addressed by embedding credentialing in the profession. RPS, in collaboration with the pharmacy profession, has been developing our credentialing model over the last 4 to 5 years and we recognise there is much work ahead of us, in continued partnership with many others in the pharmacy ecosystem, to ensure the full value of credentialing can be realised to the benefit of pharmacists, patients and the public. The changes and opportunities that lie ahead for the pharmacy profession act as a call for action for this change. Medicines, and therefore pharmacy practice, are advancing and becoming more complex; this is mirrored by patients’ healthcare needs. In tandem, the role of the pharmacist in delivering healthcare services within the wider multidisciplinary team is evolving rapidly across community, primary, and secondary care settings, including the prescribing of medicines from point of registration from 2026. We recognise that collaboration is vital in order to enable the integration of credentialing, and we are committed to continued engagement with employers across GB during 2025 and beyond to highlight the value of credentialing for them and their employed pharmacists. We will continue working closely with the Chief Pharmaceutical Officers, Pharmacy Deans and other NHS leaders, and will collaborate with professional representative bodies and other stakeholders, to demonstrate the value credentialing brings to the profession, patients and the wider healthcare system. Introducing a formal progression model into the post-registration space will involve additional effort and cost but we believe that these will be proportionate to the benefit (to patients, pharmacists and the profession) they will bring. NHS education commissioners have already supported pharmacists to engage with credentialing by, for example, providing access to the RPS post-registration foundation e-Portfolio, supporting post-registration foundation candidates through credentialing via national training programmes and funding candidates through core advanced credentialing. We will continue to advocate for employer and system support for the further rollout of credentialing. Credentialing has already been integrated into NHS policy as a requirement to progress to consultant pharmacist roles, in all sectors, including the NHS managed sector, as articulated in the NHS Consultant Pharmacist Guidance. Integrating all levels of credentialing meaningfully into the profession will require collective action and support and achieving this will not be achieved by the RPS or any future royal college in isolation. To be fully woven into the profession, credentialing needs to be integrated into job descriptions, job plans and career progression (including remuneration). We continue to drive for this through our advocacy work. And of course, pharmacists need to be supported. We agree that ensuring pharmacists have the time, space and support to develop professional practice portfolios is essential to integrating credentialing meaningfully in the profession. We have advocated for this through our Protected Learning Time policy and we recognise the need for more effective job planning. RPS curricula describe the recommended level of commitment from employers required to support a pharmacist undergoing a credentialing pathway. We’d like to emphasise that RPS credentialing is not a micro credential in a specific area of clinical practice but the assurance of a level of practice. When credentialing at core advanced level, we are assuring clinical and non-clinical capabilities (for example leadership) which align to the multiprofessional definitions of advanced practice in other professions. Where there is a patient and system need for specific clinical definition and assurance, we will continue to collaboratively develop specialist curricula, as we have done recently in critical care with the UK Clinical Pharmacy Association (UKCPA) and mental health in collaboration with the College of Mental Health Pharmacy (CMHP). The requirements of the specialist curricula can be demonstrated at the same time as the core advanced credentialing process or separately, depending on the pharmacist’s career preferences. Moving away from the question of credentialing and considering the wider ambitions of our proposal for change, we must consider governance. Governance mechanisms exist to ensure appropriate decisions are made in line with the organisation’s ambitions. Our rigorous governance review aims to embed transparency in the way we work and ensure that the future Royal College remains led by the profession. Our intent to register as a charity further ensures that there are appropriate external frameworks and scrutiny in place so that we meet our intended objective of advancing the science and practice of pharmacy, with patient and public benefit at the forefront of our work. We look forward to constructive dialogue with the Guild Council over the coming months as we refine our proposals for change and prepare to set the final proposition before our membership for a vote in early 2025. Meanwhile we invite Guild members together with all pharmacists and pharmaceutical scientists to attend one of our roadshow events and/or to find out more about the proposals for change. Yours sincerely, Paul Bennett FRPharmS, Chief Executive, Royal Pharmaceutical Society